IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 20 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $251,000 | -80.3% | 147,287 | -81.4% | 0.10% | -31.9% |
| Q3 2017 | $1,276,000 | -49.7% | 792,434 | 0.0% | 0.14% | -72.0% |
| Q2 2017 | $2,536,000 | -23.3% | 792,434 | 0.0% | 0.50% | +41.3% |
| Q1 2017 | $3,305,000 | +58.7% | 792,434 | -4.9% | 0.36% | -78.3% |
| Q4 2016 | $2,083,000 | -34.4% | 833,333 | 0.0% | 1.64% | +323.5% |
| Q3 2016 | $3,175,000 | +1.3% | 833,333 | 0.0% | 0.39% | +133.7% |
| Q2 2016 | $3,133,000 | -5.3% | 833,333 | 0.0% | 0.17% | -79.3% |
| Q1 2016 | $3,309,000 | – | 833,333 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 734,363 | $1,182,000 | 0.24% |
| MARATHON ASSET MANAGEMENT LP | 792,434 | $1,276,000 | 0.14% |
| CORRADO ADVISORS, LLC | 123,119 | $198,000 | 0.11% |
| BARD ASSOCIATES INC | 60,700 | $98,000 | 0.05% |
| Granite Investment Partners, LLC | 127,214 | $205,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 20,000 | $32,000 | 0.00% |
| Virtu Financial LLC | 15,692 | $25,000 | 0.00% |
| CITIGROUP INC | 250 | $0 | 0.00% |
| BlackRock Inc. | 71,194 | $115,000 | 0.00% |
| Bank of New York Mellon Corp | 38,816 | $62,000 | 0.00% |